EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Arginine concentration in arterial vs venous blood in a bleomycin-induced lung inflammation model in mice

Slobodan Tepic iD, Daniel Arens iD, Tim Buchholz, Dirk Nehrbass iD, Olivera Cvetkovic, Martin J Stoddart, R G Richards iD, Stephan Zeiter iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0285770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Slobodan Tepic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hepius Biotech AG, Zurich, Switzerland. Hauptthemen laut MEDLINE: COVID-19, Pneumonia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pneumonia, always a major malady, became the main public health and economic disaster of historical proportions with the COVID-19 pandemic. This study was based on a premise that pathology of lung metabolism in inflammation may have features invariant to the nature of the underlying cause. Amino acid uptake by the lungs was measured from plasma samples collected pre-terminally from a carotid artery and vena cava in mice with bleomycin-induced lung inflammation (N = 10) and compared to controls treated with saline instillation (N = 6). In the control group, the difference in concentrations between the arterial and venous blood of the 19 amino acids measured reached the level of statistical significance only for arginine (-10.7%, p = 0.0372) and phenylalanine (+5.5%, p = 0.0266). In the bleomycin group, 11 amino acids had significantly lower concentrations in the arterial blood. Arginine concentration was decreased by 21.1% (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19PneumoniaMiceHumansAnimalsArginineBleomycinEndothelial CellsCitrullinePandemicsLungNitric Oxide Synthase Type IINitric Oxide

Substanzen

ArginineBleomycinCitrullineNitric Oxide Synthase Type IINitric Oxide

Autor:innen und Institutionen

  • Hepius Biotech AG, Zurich, Switzerland.
  • AO Research Institute, Davos, Switzerland.

ORCID-Profile: Slobodan Tepic, Daniel Arens, Dirk Nehrbass, R G Richards, Stephan Zeiter

Zitieren

APA

Tepic, S., Arens, D., Buchholz, T., Nehrbass, D., Cvetkovic, O., Stoddart, M. J., Richards, R. G., & Zeiter, S. (2023). Arginine concentration in arterial vs venous blood in a bleomycin-induced lung inflammation model in mice. PLOS ONE. https://doi.org/10.1371/journal.pone.0285770

Vancouver

Tepic S, Arens D, Buchholz T, Nehrbass D, Cvetkovic O, Stoddart MJ, et al. Arginine concentration in arterial vs venous blood in a bleomycin-induced lung inflammation model in mice. PLOS ONE. 2023. doi:10.1371/journal.pone.0285770

BibTeX
@article{Tepic2023,
  author = {Tepic, Slobodan and Arens, Daniel and Buchholz, Tim and Nehrbass, Dirk and Cvetkovic, Olivera and Stoddart, Martin J and Richards, R G and Zeiter, Stephan},
  title = {Arginine concentration in arterial vs venous blood in a bleomycin-induced lung inflammation model in mice},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0285770}
}
Kostenlos starten →